Member Info for Yorkshirepragma

Summary-

- close to the line, in pharma terms 4 sure.

- entry potential to several BP wish list areas.

- sound approach ,with prizes( always meritorious and flag waving to the industry

- decent team of prospectors who know the game

- buyouts at stages 1/ early 2 for a prospective company run to $1~2 bn on a good day .

OK $1~1.5 bn likely ..

It’s also very quiet..always a sign .

GLA

Could be the unknown flyer ….

For once a comprehensive review. Designed for USA tech.

Https://www.researchnester.com/reports/biological-imaging-reagents-market/6573#:~:text=Biological%20Imaging%20Reagents%20Market%20size%20was%20estimated%20over%20at%20USD,to%20reach%20USD%2014.3%20billion

Imaging dyes global market $13bn

Another ‘ brilliant ‘ way forward…why would higher risk smaller companies attract investment? Enough of these around already!

Https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2024

Adding a clever tech. insurance policy ,a sound strategy for any oncology co.

ES, yup it’s possible at any time. If AS left because he said no way , then anytime?

One things for certain , radio silence!

If someone was to have a go , then pre USA listing might call it.

Let’s see..

GLA

Https://www.biopharmadive.com/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/

In Oct to date 2x $1bn+ acquisitions .

GLA

Https://www.iqvia.com/blogs/2024/01/biopharma-m-and-a-outlook-for-2024

H4/crowfoot .. ‘old’ bell a repro pub… try Wellington @ Darley for proper Yorkshire style( park your sheep in the car park first)regards

Bella, yup I think this one’s the key to future dev.

Brilliant alliance by Christina etal.

Great interpro…I’m keeping the lot, irrespective.

Https://www.novartis.com/sites/novartis_com/files/2024-jpm-novartis-strategy-growth-update.pdf

Aiming to be pure play innovative drugs…inc chemo

That’s tech proves its worth. ….which it seems on track to do. Some of the best ‘names in chemo oncology’ ,have put their names against this co,

Not something ‘factored in’ by financial alogorithm.

And it’s a great ‘cause’ to invest in.

Https://www.gminsights.com/industry-analysis/oncology-market?gbraid=0AAAAACuPGhWjcH0NnUk6XSAwwcGTEcoFa

$430bn by 2032.

9/5 chance Av w I’ll be providing small part of this , 3/1 a large part if te h proves its worth.

I’d say stick!

GLA

Https://www.merck.com/news/daiichi-sankyo-and-merck-announce-global-development-and-commercialization-collaboration-for-three-daiichi-sankyo-dxd-adcs/

GLA

…& it will be odd tactics to reveal the tech without ( development support’, ie a business way forward.

GLA

The only thing you can be sure of is you’ll not know till it happens . Shhhh

Https://www.technologynetworks.com/drug-discovery/articles/drug-repurposing-strategies-challenges-and-successes-384263